Andrea Necchi Md

Screening novel neoadjuvant therapies for urothelial carcinoma

Updates from KEYNOTE-905: immunotherapy + cystectomy vs cystectomy alone in MIBC

Combining ADC’s with other novel agents in the frontline treatment of urothelial carcinoma

Positive biomarkers to select patients for bladder preservation in bladder cancer

Examining the State of the Science on New Therapies in Bladder Cancer

PeerView Oncology

Results from dataset analysis of CDH1-mutated urothelial carcinoma patients

Optimizing treatment options for patients with muscle-invasive urothelial carcinoma

Genomic landscape and tumor neoantigen burden for penile squamous cell cancer

Updates in the field of bladder cancer from ESMO 2023

SunRISe-3: TAR-200 + CET or TAR-200 vs BCG in BCG-naive HR NMIBC

Dr. Necchi on Impact of PD-1 Inhibition in Bladder Cancer

How effective are ADCs in treating metastatic urothelial cancer?

Interview with dr. Andrea Necchi about targeted agents for advanced bladder cancer

CheckMate 274: biomarkers linked to disease-free survival with adjuvant nivolumab

KEYNOTE-057 Cohort B: pembrolizumab for BCG-unresponsive, high-risk NMIBC

The Global Society of Rare Genitourinary Tumors (GSRGT) w/ Dr. Spiess & Dr. Necchi | Ep. 170

BackTable Urology Podcast

Полупромышленная швейная машина NECCHI 7575AT | Заправка, операции, характеристики, комплектация

Швейные машины NECCHI | Официальный канал